XML 111 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present the fair value of assets and liabilities measured at fair value on a recurring basis as of December 31, 2024 and 2023 (dollars in millions):
December 31, 2024
Fair Value Measured and Recorded Using
Level 1Level 2Level 3Total
Assets
Available for sale debt securities:
U.S. treasury securities$$— $— $
Corporate debt securities— 33 — 33 
Asset-backed securities— — 
Total available for sale debt securities40 — 43 
Equity securities18 — — 18 
Investments in unconsolidated subsidiaries100 — 412 512 
Warehouse receivables— 561 — 561 
Derivative assets— 43 — 43 
Other assets— — 46 46 
Total assets at fair value$121 $644 $458 $1,223 
Liabilities
Contingent consideration— — 36 36 
Total liabilities at fair value$— $— $36 $36 
December 31, 2023
Fair Value Measured and Recorded Using
Level 1Level 2Level 3Total
Assets
Available for sale debt securities:
U.S. treasury securities$12 $— $— $12 
Debt securities issued by U.S. federal agencies— 11 — 11 
Corporate debt securities— 44 — 44 
Asset-backed securities— — 
Total available for sale debt securities12 56 — 68 
Equity securities41 — — 41 
Investments in unconsolidated subsidiaries168 — 477 645 
Warehouse receivables— 675 — 675 
Other assets— — 16 16 
Total assets at fair value$221 $731 $493 $1,445 
Liabilities
Contingent consideration— — 36 36 
Derivative liabilities— — 
Total liabilities at fair value$— $$36 $41 
Schedule of Reconciliation for Assets Measured at Fair Value
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (dollars in millions):
Investment in Unconsolidated SubsidiariesOther AssetsContingent Consideration
Balance as of December 31, 2022$461 $14 $41 
Transfer in (out)— (10)— 
Net change in fair value16 (6)
Purchases/ Additions— 20 
Sales / Payments— — (19)
Balance as of December 31, 2023477 16 36 
Transfer in (out)— — — 
Net change in fair value(65)18 (5)
Purchases/ Additions— 12 11 
Sales / Payments— — (6)
Balance as of December 31, 2024$412 $46 $36 
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiariesEquity (loss) income from unconsolidated subsidiaries
Other assets (liabilities)Other income (loss)
Contingent consideration (short-term)Accounts payable and accrued expenses
Contingent consideration (long-term)Other liabilities
Schedule of Reconciliation for Liabilities Measured at Fair Value
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (dollars in millions):
Investment in Unconsolidated SubsidiariesOther AssetsContingent Consideration
Balance as of December 31, 2022$461 $14 $41 
Transfer in (out)— (10)— 
Net change in fair value16 (6)
Purchases/ Additions— 20 
Sales / Payments— — (19)
Balance as of December 31, 2023477 16 36 
Transfer in (out)— — — 
Net change in fair value(65)18 (5)
Purchases/ Additions— 12 11 
Sales / Payments— — (6)
Balance as of December 31, 2024$412 $46 $36 
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiariesEquity (loss) income from unconsolidated subsidiaries
Other assets (liabilities)Other income (loss)
Contingent consideration (short-term)Accounts payable and accrued expenses
Contingent consideration (long-term)Other liabilities
Significant Unobservable Inputs Used for Recurring Fair Value Measurements for Certain Level 3 Instruments
The table below presents information about the significant unobservable inputs used for recurring fair value measurements for certain Level 3 instruments as of December 31, 2024:
Valuation TechniqueUnobservable Input
Investment in unconsolidated subsidiariesDiscounted cash flowDiscount rate13 %
Monte CarloVolatility62 %
Other assetsDiscounted cash flowDiscount rate13 %
Contingent consideration
Monte Carlo
Volatility21 %
Discount rate
%
Discounted estimated payments (1)
Discount rate
5% - 6%
________________________________________________________________________________________________________________________________________
(1)As of December 31, 2024, discounted estimated payments for Contingent Consideration had a weighted average of 6%.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
Estimated Fair ValueCarrying Value
Financial instrumentDecember 31, 2024December 31, 2023December 31, 2024December 31, 2023
Senior term loans
$708 $746 $718 $752 
5.950% senior notes
1,033 1,049 976 974 
4.875% senior notes
600 600 599 597 
5.500% senior notes
509 — 496 — 
2.500% senior notes
426 424 492 490